Third Patient Dies After Receiving Six Times the Required Drug Dose at Spanish Hospital

Third Death at Burgos Hospital Following Overdose Error

A third cancer patient has died at Burgos University Hospital after receiving six times the correct dose of the oncology drug Cabazitaxel. The patient had been in the intensive care unit since December 2025, when the dosage error first occurred. Two further patients who also received overdoses have since been discharged.

Hospital sources confirmed that the death resulted directly from the overdose administration. A Burgos court is now investigating potential crimes of reckless homicide and injury, after the Prosecutor's Office received complaints suggesting "the possible existence of the crime of homicide by recklessness."

How the Error Happened

The root cause has been traced to the introduction of a new electronic prescription system in the hospital's Oncology and Haematology department on December 2, 2025. When the system was rolled out, medical staff failed to enter the correct dosage details for Cabazitaxel in the computer database.

As a result, the prescribed drug was not diluted to the correct concentration before being administered to patients — meaning those who received it were given six times the dose they should have been. Hospital officials have attributed the incident to "human error" in the data entry process during the system transition.

The Scale of the Review

In the wake of the incident, authorities launched a comprehensive audit of the new system's database. Investigators are now examining approximately 2,000 active ingredients and 400 oncology drug records that were incorporated into the new system — to establish whether any other dosage errors may have been introduced during the transition.

The scope of that review underlines how significant a system migration of this kind is, and how much depends on accurate data entry when a hospital moves from one prescribing platform to another.

Responsibility and Compensation

Both Spain's Ministry of Health and Castilla y León's Regional Health Management have confirmed responsibility for providing civil compensation to the families of the victims. The acknowledgement of liability at institutional level will be of some importance to the families as the criminal proceedings continue.

The criminal investigation, however, is focused on individual accountability — specifically, whether the actions or omissions of those involved in setting up and implementing the new system rise to the level of criminal recklessness under Spanish law.

What Is Cabazitaxel

Cabazitaxel is a chemotherapy drug used primarily in the treatment of prostate cancer that has stopped responding to other treatments. It is classified as a cytotoxic agent — meaning it is designed to kill rapidly dividing cells, and must be handled and administered with great precision. At correct doses it is a vital treatment; at six times the correct dose, the consequences for the human body are severe and potentially fatal.

It is precisely because drugs like Cabazitaxel have such a narrow margin between therapeutic and toxic doses that electronic prescription systems — properly implemented — are considered a major safety improvement over paper-based processes. The tragedy in Burgos illustrates what can go wrong when the transition to such a system is not handled with sufficient care.

A System Failure with Human Consequences

This case raises serious questions about the protocols hospitals use when migrating to new electronic prescribing systems — in particular, the verification steps that should be in place to check that dosage data has been transferred correctly before any patient receives medication under the new system.

For the families of the three patients who have died, and for those who received overdoses and survived, no finding of institutional or individual responsibility will undo the harm that has been done. The court proceedings will determine what accountability looks like in the eyes of Spanish law.

This article is based on reporting from The Olive Press, published April 23, 2026. The criminal investigation is ongoing. All individuals under investigation are presumed innocent until proven guilty.